126 related articles for article (PubMed ID: 23965852)
1. [Cellular pathology of neurodegenerative disorders].
Wakabayashi K
Rinsho Shinkeigaku; 2013; 53(8):609-17. PubMed ID: 23965852
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain.
Wakabayashi K; Mori F; Tanji K; Orimo S; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):1-12. PubMed ID: 20532896
[TBL] [Abstract][Full Text] [Related]
3. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
4. [Pathology of basal ganglia in neurodegenerative diseases].
Wakabayashi K; Tanji K; Mori F
Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
[TBL] [Abstract][Full Text] [Related]
5. [TDP-43 proteinopathies - from frontotemporal lobar degeneration to inclusion body myositis].
Kierdaszuk B; Berdyński M; Zekanowski C; Kamińska A
Neurol Neurochir Pol; 2012; 46(4):384-91. PubMed ID: 23023438
[TBL] [Abstract][Full Text] [Related]
6. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
[TBL] [Abstract][Full Text] [Related]
7. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
[TBL] [Abstract][Full Text] [Related]
8. Interactions of pathological proteins in neurodegenerative diseases.
Spires-Jones TL; Attems J; Thal DR
Acta Neuropathol; 2017 Aug; 134(2):187-205. PubMed ID: 28401333
[TBL] [Abstract][Full Text] [Related]
9. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
[TBL] [Abstract][Full Text] [Related]
10. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.
Arnold SE; Toledo JB; Appleby DH; Xie SX; Wang LS; Baek Y; Wolk DA; Lee EB; Miller BL; Lee VM; Trojanowski JQ
J Comp Neurol; 2013 Dec; 521(18):4339-55. PubMed ID: 23881776
[TBL] [Abstract][Full Text] [Related]
11. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 pathology occurs infrequently in multiple system atrophy.
Geser F; Malunda JA; Hurtig HI; Duda JE; Wenning GK; Gilman S; Low PA; Lee VM; Trojanowski JQ
Neuropathol Appl Neurobiol; 2011 Jun; 37(4):358-65. PubMed ID: 20942898
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
14. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
15. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner.
Ferrer I
Prog Neurobiol; 2018 Oct; 169():24-54. PubMed ID: 30077775
[TBL] [Abstract][Full Text] [Related]
17. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
[TBL] [Abstract][Full Text] [Related]
18. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
Hauw JJ; Hausser-Hauw C; Duyckaerts C
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
[TBL] [Abstract][Full Text] [Related]
19. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
20. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]